Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 86 of the 88 references it cites were found in a registry or an index; 9 of the 67 sources its claims cite were checked for support.

Acceptability, effectiveness and cost-effectiveness of blended cognitive-behavioural therapy (bCBT) versus face-to-face CBT (ftfCBT) for anxiety disorders in specialised mental health care: A 15-week randomised controlled trial with 1-year follow-up

Open access
Romijn, Geke, Batelaan, Neeltje, Koning, Jeroen, van Balkom, Anton, de Leeuw, Aart, Benning, Friederike, Hakkaart van Roijen, Leona, Riper, Heleen · 2021 · PLOS ONE

Abstract

Background: Anxiety disorders are highly prevalent and cause substantial economic burden. Blended cognitive-behavioural therapy (bCBT), which integrates Internet-based CBT and face-to-face CBT (ftfCBT), is an attractive and potentially cost-saving treatment alternative to conventional CBT for patients with anxiety disorders in specialised mental health care. However, little is known about the effectiveness of bCBT in routine care. We examined the acceptability, effectiveness and cost-effectiveness of bCBT versus ftfCBT in outpatient specialised care to patients with panic disorder, social anxiety disorder and generalised anxiety disorder. Methods and findings: Patients with anxiety disorders were randomised to bCBT (n = 52) or ftfCBT (n = 62). Acceptability of bCBT and ftfCBT were evaluated by assessing treatment preference, adherence, satisfaction and therapeutic alliance. Costs and effects were assessed at post-treatment and one-year follow-up. Primary outcome measure was the Beck Anxiety Inventory (BAI). Secondary outcomes were depressive symptoms, general psychopathology, work and social adjustment, quality of life and mastery. Incremental cost-effectiveness ratios (ICERs) were computed from societal and healthcare perspectives by calculating the incremental costs per incremental quality-adjusted life year (QALY). No significant differences between bCBT and ftfCBT were found on acceptability or effectiveness measures at post-treatment (Cohen’s d between-group effect size on BAI = 0.15, 95% CI −0.30 to 0.60) or at one-year follow-up (d = −0.38, 95% CI −0.84 to 0.09). The modelled point estimates of societal costs (bCBT €10945, ftfCBT €10937) were higher and modelled point estimates of direct medical costs (bCBT €3748, ftfCBT €3841) were lower in bCBT. The acceptability curves showed that bCBT was expected to be a cost-effective intervention. Results should be carefully interpreted due to the small sample size. Conclusions: bCBT appears an acceptable, clinically effective and potentially cost-saving alternative option for treating patients with anxiety disorders. Trials with larger samples are needed to further investigate cost-effectiveness. Trial registration: Netherlands Trial Register: NTR4912.

Overview

CoChat Summary

## TL;DR

This 15-week randomized controlled trial compared blended CBT (bCBT) with face-to-face CBT (ftfCBT) for panic disorder, social anxiety disorder, and generalized anxiety disorder in Dutch specialized mental health care. bCBT was similarly acceptable and clinically effective as ftfCBT, and it had lower direct medical costs with slightly higher QALYs over 1 year, suggesting cost-effectiveness.

## Key findings

  • Sample and follow-up: 114 patients were randomized (bCBT n = 52, ftfCBT n = 62); mean age was 36.3 years and 60.5% were female. Post-treatment data were available for 77/114 (67.5%) and 1-year follow-up data for 74/114 (64.9%).
  • Acceptability: Before randomization, 54.4% of patients preferred bCBT over ftfCBT. Treatment adherence was 67.4% completed prescribed sessions in bCBT vs 61.6% in ftfCBT, and treatment completion was 59.6% vs 51.6%, respectively; none of these differences were statistically significant.
  • Effectiveness: No significant between-group differences were found for anxiety severity at post-treatment (t = -0.715, p = 0.477) or 1-year follow-up (t = 1.702, p = 0.093). Within-group anxiety effect sizes were d = 0.73 (bCBT) and d = 0.55 (ftfCBT) at post-treatment, and d = 0.50 (bCBT) and d = 1.00 (ftfCBT) at follow-up.
  • Costs and QALYs: Over 1 year, direct medical costs were €3758 for bCBT and €3841 for ftfCBT, with a statistically significant difference (mean -83.78, 95% CI -96.96 to -70.61, p < 0.001). QALYs were 0.66 for bCBT and 0.62 for ftfCBT (mean 0.037, 95% CI 0.036 to 0.038, p < 0.001), yielding an ICER of €-2257 per QALY from the healthcare perspective and €219 per QALY from the societal perspective.

## Methods

  • Parallel-group randomized controlled trial in outpatient specialized mental health care in the Netherlands, with assessments at baseline, 15 weeks (post-treatment), and 52 weeks (1-year follow-up).
  • Included adults with DSM-IV panic disorder, social anxiety disorder, or generalized anxiety disorder; 114 participants were randomized across four sites, with stratified block randomization and no blinding of patients or therapists.
  • Primary outcome was anxiety severity on the Beck Anxiety Inventory (BAI); secondary outcomes included depressive symptoms, general psychopathology, mastery, work/social functioning, quality of life, and costs/QALYs. Clinical outcomes were analyzed with linear mixed models under an ITT approach; costs and QALYs were analyzed with generalized linear models and multiple imputation.

## Limitations

  • The paper states the sample was smaller than expected: 114 participants were included instead of the intended 156, so only “initial indications” of cost-effectiveness could be explored.
  • There was substantial study dropout, with 35.1% missing at 1-year follow-up; this was not considered in the power calculation.
  • Participants and therapists could not be blinded to treatment allocation, which the paper says may have affected results.
  • Evident from the text: the study was conducted in specialized mental health care in the Netherlands with anxiety disorders only, which limits generalizability beyond this setting and these diagnoses.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0259493

Cites

86 of 86 references verified0 citation errors · 0 not checkable

Statistics

3 tests recomputed · 1 with the reported and recomputed p on opposite sides of .05

Figures

Fig 1 CONSORT flow diagram of participants.
Fig 1 CONSORT flow diagram of participants.CC BY · PubMed Central
Fig 2 CE plane for healthcare perspective.
Fig 2 CE plane for healthcare perspective.CC BY · PubMed Central
Fig 3 CE plane for societal perspective.
Fig 3 CE plane for societal perspective.CC BY · PubMed Central
Fig 4 Cost acceptability curves from the societal perspective and health care perspective.
Fig 4 Cost acceptability curves from the societal perspective and health care perspective.CC BY · PubMed Central

Verification

Claims the paper makes

6 Valid · 0 Not valid · 38 Not checked · 69 Own results and interpretations

39 more claims

Create a free account to see all 113 claims and to verify the 58 references still open.

See all claims — free account
  • Probably not a substantial claim. 47
  • It may state two separate claims as one. 38

Create a free account to see these claims.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Statistics that don’t add up

Each reported p-value recomputed from its test statistic and degrees of freedom.

2 of 2

Statistics recomputed

Every reported test result, recomputed from its test statistic and degrees of freedom. A result shows as not adding up only once an independent check has confirmed it.

  • Doesn’t add upχ²(2) = 4.84reported p = .028 · recomputed p = .089The two fall on opposite sides of .05

    “χ2 (2) = 4.84, p = .028”

  • Doesn’t add upχ²(1) = 0.78reported p = .781 · recomputed p = .377

    “χ2 (1) = 0.78, p = .781”

  • Consistentχ²(1) = 0.23reported p = .629 · recomputed p = .632

    “χ2 (1) = 0.23, p = .629”

3 of 3

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

2 of 2

Citations

Cites

Show all 88 references

Research works printed but not linked: 10

  1. NICE, 2011, Generalised anxiety disorder and panic disorder in adults., Natl Inst Heal Clin Excell
  2. National Institute for Health and Care Excellence, 2013, Social anxiety disorder: recognition, assessment and treatment., Clinical guideline 159
  3. H Riper, 2013, Preventie & eMental-health. Onderzoek dat leidt, technologie die verleidt, preventie die bereikt en beklijft., Kennissynthese 2013 in opdracht van ZonMw. Amsterdam
  4. MB First, 2002, Structured Clinical Interview for DSM-IV-TR Axis I Disorders.
  5. IM Van Vliet, 2007, Het Mini Internationaal Neuropsychiatrisch Interview (MINI): Een kort gestructureerd diagnostisch psychiatrisch interview voor DSM-IV-en ICD-10-stoornissen., Tijdschr Psychiatr, 49, 393
  6. W. Van der Does, 2002, De Nederlandse versie van de Beck Depression Inventory-2nd edition.
  7. EDE Beurs, 2006, De Brief Symptom Inventory., Maandbl Geestelijke Volksgezond, 61, 120
  8. L Hakkaart-van Roijen, 2015, Kostenhandleiding: Methodologie van kostenonderzoek en referentieprijzen voor economische evaluaties in de gezondheidszorg., Zorginstituut Ned.
  9. 1990, EuroQol—a new facility for the measurement of health-related quality of life, Health Policy (New York), 16, 199, 10.1016/0168-8510(90)90421-9 · DOI · Paper page
  10. L Hakkaart-van Roijen, 2016, Kostenhandleiding: Methodologie van kostenonderzoek en referentieprijzen voor economische evaluaties in de gezondheidszorg., Dutch Natl Heal Care Inst, 1

Cited by

See all 47

Metadata

Authors
Romijn, G., Batelaan, N., Koning, J., van Balkom, A., de Leeuw, A., Benning, F., Hakkaart van Roijen, L., & Riper, H.
Affiliations
  • GGz Breburg (NL)
  • Amsterdam Public Health (NL)
  • Erasmus University Rotterdam (NL)
Corresponding author
Romijn, Geke
Venue
PLOS ONE
Published
2021-11-12
Volume
16
Issue
11
Pages
e0259493
ISSN
1932-6203 (ISSN-L)
OpenAlex
W3213316242
Cited by
46
References
88
Citations by year
2026: 10 · 2025: 11 · 2024: 11 · 2023: 8 · 2022: 4 · 2021: 1
FWCI
5.39
Type
journal article
Language
en
Open access
Locations
  • PLoS ONE (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Amsterdam UMC (VU Amsterdam) - Institutional Repository (publishedVersion, other-oa)
  • EUR Research Repository (Erasmus University Rotterdam) (publishedVersion, cc-by)
  • VU Research Portal (publishedVersion, other-oa)
  • Pure Amsterdam UMC (submittedVersion, cc-by)
  • EUR Research Repository (Erasmus University Rotterdam) (submittedVersion, cc-by)
  • RePEc: Research Papers in Economics (submittedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • University of Southern Denmark Research Portal (University of Southern Denmark) (submittedVersion, cc-by)
  • Data Archiving and Networked Services (DANS) (submittedVersion, cc-by)
Funders
ZonMw (837002505)
Topics
  • Social Sciences › Psychology › Applied Psychology › Digital Mental Health Interventions
  • Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Telemedicine and Telehealth Implementation
Keywords
internet-based CBT, anxiety disorders, panic disorder, social anxiety disorder, generalized anxiety disorder, cost-effectiveness, acceptability, outpatient care, quality-adjusted life years, medication adherence, therapeutic relationship, depressive symptoms, quality of life, work and social adjustment, mastery, social costs, health care costs
MeSH terms
Adult, Anxiety Disorders, Cost-Benefit Analysis, Female, Follow-Up Studies, Humans, Male, Middle Aged, Cognitive Behavioral Therapy, Telemedicine

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (qwen3.8-omni-flash and gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Acceptability, effectiveness and cost-effectiveness of blended cognitive-behavioural therapy (bCBT) versus face-to-face CBT (ftfCBT) for anxiety disorders in specialised mental health care: A 15-week randomised controlled trial with 1-year follow-up. https://app.cochat.ai/papers/10.1371/journal.pone.0259493
The paper
Romijn, G., Batelaan, N., Koning, J., van Balkom, A., de Leeuw, A., Benning, F., Hakkaart van Roijen, L., & Riper, H. (2021). Acceptability, effectiveness and cost-effectiveness of blended cognitive-behavioural therapy (bCBT) versus face-to-face CBT (ftfCBT) for anxiety disorders in specialised mental health care: A 15-week randomised controlled trial with 1-year follow-up. PLOS ONE. https://doi.org/10.1371/journal.pone.0259493

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.